- Home
- AUTL vs SMBK Comparison
AUTL vs SMBK Comparison
Compare AUTL & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- SMBK
- Stock Information
- Founded
- AUTL 2014
- SMBK N/A
- Country
- AUTL United Kingdom
- SMBK United States
- Employees
- AUTL N/A
- SMBK N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- SMBK Major Banks
- Sector
- AUTL Health Care
- SMBK Finance
- Exchange
- AUTL Nasdaq
- SMBK Nasdaq
- Market Cap
- AUTL 590.8M
- SMBK 534.5M
- IPO Year
- AUTL 2018
- SMBK N/A
- Fundamental
- Price
- AUTL $2.17
- SMBK $35.32
- Analyst Decision
- AUTL Strong Buy
- SMBK Buy
- Analyst Count
- AUTL 3
- SMBK 6
- Target Price
- AUTL $10.20
- SMBK $30.50
- AVG Volume (30 Days)
- AUTL 1.1M
- SMBK 55.9K
- Earning Date
- AUTL 03-13-2025
- SMBK 01-21-2025
- Dividend Yield
- AUTL N/A
- SMBK 0.91%
- EPS Growth
- AUTL N/A
- SMBK 26.63
- EPS
- AUTL N/A
- SMBK 2.14
- Revenue
- AUTL $10,091,000.00
- SMBK $166,349,000.00
- Revenue This Year
- AUTL $851.83
- SMBK N/A
- Revenue Next Year
- AUTL $224.65
- SMBK $9.70
- P/E Ratio
- AUTL N/A
- SMBK $16.24
- Revenue Growth
- AUTL 82.71
- SMBK 11.36
- 52 Week Low
- AUTL $2.07
- SMBK $19.00
- 52 Week High
- AUTL $7.37
- SMBK $37.72
- Technical
- Relative Strength Index (RSI)
- AUTL 41.81
- SMBK 61.57
- Support Level
- AUTL $2.11
- SMBK $34.88
- Resistance Level
- AUTL $2.26
- SMBK $35.87
- Average True Range (ATR)
- AUTL 0.12
- SMBK 0.86
- MACD
- AUTL 0.01
- SMBK 0.36
- Stochastic Oscillator
- AUTL 27.78
- SMBK 77.62
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.